tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RCKT Stock Latest News

Rocket Pharmaceuticals price target lowered to $15 from $29 at Goldman Sachs
The FlyRocket Pharmaceuticals price target lowered to $15 from $29 at Goldman Sachs
1h ago
RCKT
Rocket Pharmaceuticals price target lowered to $54 from $62 at Chardan
PremiumThe Fly
Rocket Pharmaceuticals price target lowered to $54 from $62 at Chardan
14h ago
RCKT
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Reiterated with $32 Price Target
PremiumRatings
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Reiterated with $32 Price Target
14h ago
RCKT
Positive Outlook for Rocket Pharmaceuticals Amidst Regulatory Progress and Financial Stability
PremiumRatings
Positive Outlook for Rocket Pharmaceuticals Amidst Regulatory Progress and Financial Stability
14h ago
RCKT
Promising Pipeline and Market Opportunities Drive Buy Rating for Rocket Pharmaceuticals
PremiumRatings
Promising Pipeline and Market Opportunities Drive Buy Rating for Rocket Pharmaceuticals
15h ago
RCKT
Rocket Pharmaceuticals reports Q4 EPS (62c), consensus (72c)
PremiumThe FlyRocket Pharmaceuticals reports Q4 EPS (62c), consensus (72c)
1d ago
RCKT
Rocket Pharmaceuticals price target lowered to $48 from $49 at JPMorgan
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $48 from $49 at JPMorgan
2M ago
RCKT
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
CVM
CDTX
Boeing slips after Jeju Air crash, HashiCorp-IBM draws review: Morning Buzz
PremiumThe Fly
Boeing slips after Jeju Air crash, HashiCorp-IBM draws review: Morning Buzz
2M ago
T
BA
American Air upgraded, Nordstrom downgraded: Wall Street’s top analyst calls
PremiumThe Fly
American Air upgraded, Nordstrom downgraded: Wall Street’s top analyst calls
2M ago
AAL
JWN
Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’
PremiumThe Fly
Wedbush starts Rocket Pharmaceuticals with Outperform into ‘inflection year’
2M ago
RCKT
Rocket Pharmaceuticals initiated with an Outperform at Wedbush
PremiumThe Fly
Rocket Pharmaceuticals initiated with an Outperform at Wedbush
2M ago
RCKT
Rocket Pharmaceuticals initiated with a Buy at Jefferies
PremiumThe FlyRocket Pharmaceuticals initiated with a Buy at Jefferies
2M ago
RCKT
Rocket Pharmaceuticals price target lowered to $40 from $44 at Leerink
Premium
The Fly
Rocket Pharmaceuticals price target lowered to $40 from $44 at Leerink
3M ago
RCKT
Rocket Pharmaceuticals 13.2M share Spot Secondary priced at $12.50
Premium
The Fly
Rocket Pharmaceuticals 13.2M share Spot Secondary priced at $12.50
3M ago
RCKT
Closing Bell Movers: Dave & Busters down 11% after Q3 miss
PremiumThe Fly
Closing Bell Movers: Dave & Busters down 11% after Q3 miss
3M ago
FEIM
FIGS
Rocket Pharmaceuticals announces $150M common stock offering
PremiumThe Fly
Rocket Pharmaceuticals announces $150M common stock offering
3M ago
RCKT
Rocket Pharmaceuticals Advances Genetic Therapies Pipeline
PremiumCompany Announcements
Rocket Pharmaceuticals Advances Genetic Therapies Pipeline
3M ago
RCKT
Rocket Pharmaceuticals Advances Danon Disease and PKD Studies
PremiumCompany Announcements
Rocket Pharmaceuticals Advances Danon Disease and PKD Studies
3M ago
8K
RCKT
Rocket Pharmaceuticals has not initiated enrollment in Phase 2 RP-L301 study
PremiumThe FlyRocket Pharmaceuticals has not initiated enrollment in Phase 2 RP-L301 study
3M ago
RCKT
Rocket Pharmaceuticals announces publication of Phase 1 RP-A501 long-term data
Premium
The Fly
Rocket Pharmaceuticals announces publication of Phase 1 RP-A501 long-term data
3M ago
RCKT
Rocket Pharmaceuticals price target raised to $51 from $50 at Scotiabank
Premium
The Fly
Rocket Pharmaceuticals price target raised to $51 from $50 at Scotiabank
4M ago
RCKT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >